Lensar (LNSR) Return on Capital Employed Growth (1y) (2021 - 2026)
Lensar (LNSR) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 216.00 |
| 10 | Lensar | 101.57 Mn | 88.01 Mn | 9.78 Mn | 1,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,829.00 |
| Mar 31, 2026 | -39.00 |
| Dec 31, 2025 | -5,957.00 |
| Sep 30, 2025 | -3,592.00 |
| Jun 30, 2025 | -1,054.00 |
| Mar 31, 2025 | -1,338.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | -486.00 |
| Jun 30, 2024 | 270.00 |
| Mar 31, 2024 | 2,199.00 |
| Dec 31, 2023 | 2,509.00 |
| Sep 30, 2023 | 2,593.00 |
| Jun 30, 2023 | 2,151.00 |
| Mar 31, 2023 | -266.00 |
| Dec 31, 2022 | -1,241.00 |
| Sep 30, 2022 | -945.00 |
| Jun 30, 2022 | -1,643.00 |
| Mar 31, 2022 | -874.00 |
| Dec 31, 2021 | -766.00 |